Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Prosacea** is a marketed over-the-counter topical gel for **rosacea** developed and marketed by **Alva-Amco**. It is a **topical small-molecule consumer OTC product** whose labeled active ingredient is **sulphur 1x** in a homeopathic preparation, described in the provided context as equivalent to approximately 1% sulphur and used for relief of common rosacea symptoms such as facial redness, papules, pustules, irritation, and inflammation. The product is a lightweight water-based gel containing aloe vera and is positioned for daily facial application. Its therapeutic activity is described broadly as modulation of inflammatory processes associated with rosacea, but the precise target-level mechanism for the homeopathic sulphur component is not clearly defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prosacea.